MoneyWorks4Me

Hikal - Quaterly Results

26 Oct 2021 Evaluate
The sales surged to Rs. 4690.60 millions, up 26.12% for the September 2021 quarter as against Rs. 3719.20 millions during the corresponding quarter previous year.Profit after tax for the quarter ended September 2021 reported a huge growth of 63.45% to Rs. 440.50  millions from Rs. 269.50 millions.Operating profit surged to 917.60 millions from the corresponding previous quarter of 707.20 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 4690.60 3719.20 26.12 9258.40 7246.90 27.76 17204.40 15072.60 14.14
Other Income 8.70 9.50 -8.42 40.50 15.90 154.72 49.80 37.00 34.59
PBIDT 917.60 707.20 29.75 1906.60 1239.00 53.88 3278.70 2768.50 18.43
Interest 79.60 85.00 -6.35 159.50 181.80 -12.27 362.00 524.20 -30.94
PBDT 838.00 622.20 34.68 1747.10 1057.20 65.26 2916.70 2090.30 39.53
Depreciation 242.00 211.70 14.31 467.60 418.80 11.65 852.40 824.60 3.37
PBT 596.00 410.50 45.19 1279.50 638.40 100.42 2064.30 1265.70 63.10
TAX 155.50 141.00 10.28 334.00 218.90 52.58 732.80 421.40 73.90
Deferred Tax -4.70 -4.30 9.30 -15.10 -6.70 125.37 -62.70 74.40 -184.27
PAT 440.50 269.50 63.45 945.50 419.50 125.39 1331.50 844.30 57.70
Equity 246.60 246.60 0.00 246.60 246.60 0.00 246.60 246.60 0.00
PBIDTM(%) 19.56 19.01 2.88 20.59 17.10 20.45 19.06 18.37 3.75
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..